Denise Treue

1.5k total citations
18 papers, 399 citations indexed

About

Denise Treue is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Denise Treue has authored 18 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Denise Treue's work include Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Denise Treue is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Denise Treue collaborates with scholars based in Germany, United States and United Kingdom. Denise Treue's co-authors include Frederick Klauschen, Jan Budczies, Carsten Denkert, Manfred Dietel, Michael Bockmayr, Michael Hummel, Annika Lehmann, Hermann Lage, Ruža Arsenić and Philipp Jurmeister and has published in prestigious journals such as Bioinformatics, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Denise Treue

18 papers receiving 396 citations

Peers

Countries citing papers authored by Denise Treue

Since Specialization

Citations

This map shows the geographic impact of Denise Treue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise Treue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise Treue more than expected).

Fields of papers citing papers by Denise Treue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise Treue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise Treue. The network helps show where Denise Treue may publish in the future.

Co-authorship network of co-authors of Denise Treue

This figure shows the co-authorship network connecting the top 25 collaborators of Denise Treue. A scholar is included among the top collaborators of Denise Treue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise Treue. Denise Treue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Distinct immune evasion in APOBEC ‐enriched, HPV ‐negative HNSCC 2020 ·International Journal of Cancer ·(unknown), Benedikt Obermayer, Konrad Klinghammer, Sebastian Ochsenreither, Denise Treue, Albrecht Stenzinger, Hanno Glimm, Stefan Fröhling, Thomas Kindler, Christian Brandts, Klaus Schulze‐Osthoff, Wilko Weichert, Ingeborg Tinhofer, Frederick Klauschen, Ulrich Keilholz, Dieter Beule, Damian Rieke	12
2	Novel methods for in vitro modeling of pancreatic cancer reveal important aspects for successful primary cell culture 2020 ·BMC Cancer ·(unknown), Jörg Arndt, Denise Treue, Philip Bischoff, Florian N. Loch, (unknown), Katja Kotsch, Frederick Klauschen, Katharina Beyer, Georgios Antonios Margonis, Martin E. Kreis, Carsten Kamphues	17
3	Multiclass cancer classification in fresh frozen and formalin-fixed paraffin-embedded tissue by DigiWest multiplex protein analysis 2020 ·Laboratory Investigation ·(unknown), Gerrit Erdmann, Denise Treue, Philipp Jurmeister, Julia Schneider, (unknown), Daniel Heim, Michael Bockmayr, Christoph Sachse, Frederick Klauschen	3
4	TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial 2020 ·Clinical Cancer Research ·Marianne Sinn, Bruno V. Sinn, Denise Treue, Ulrich Keilholz, Frédérik Damm, Rosa Schmuck, Philipp Lohneis, Frederick Klauschen, Jana K. Striefler, Marcus Bahra, Hendrik Bläker, Sven Bischoff, Uwe Pelzer, Helmut Oettle, Hanno Riess, Jan Budczies, Carsten Denkert	29
5	TFE3 activation in a TSC1‐altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms 2020 ·The Journal of Pathology Clinical Research ·(unknown), Anna Dolnik, Uwe Kornak, Berit M. Pfitzner, Michael Hummel, Denise Treue, Arndt Hartmann, Abbas Agaimy, Veronika Weyerer, (unknown), Susanne Brakemeier, Robert W. Peters, Robert Öllinger, Sven Märdian, Lars Bullinger, Jana K. Striefler, Anne Flörcken	18
6	Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases 2019 ·Science Translational Medicine ·Philipp Jurmeister, Michael Bockmayr, Philipp Seegerer, (unknown), Denise Treue, Grégoire Montavon, Claudia Vollbrecht, Alexander Arnold, Daniel Teichmann, Keno K. Bressem, Ulrich Schüller, Maximilian von Laffert, Klaus‐Robert Müller, David Capper, Frederick Klauschen	78
7	Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options 2019 ·Lung Cancer ·Philipp Jurmeister, Claudia Vollbrecht, Anke Behnke, Nikolaj Frost, Alexander Arnold, Denise Treue, Jens‐Carsten Rückert, Jens Neudecker, Leonille Schweizer, Frederick Klauschen, David Horst, Michael Hummel, Manfred Dietel, Maximilian von Laffert	21
8	Proteogenomic systems analysis identifies targeted therapy resistance mechanisms in EGFR‐mutated lung cancer 2018 ·International Journal of Cancer ·Denise Treue, Michael Bockmayr, Albrecht Stenzinger, Daniel Heim, Svenja Hester, Frederick Klauschen	7
9	Multilayered Omics-Based Analysis of a Head and Neck Cancer Model of Cisplatin Resistance Reveals Intratumoral Heterogeneity and Treatment-Induced Clonal Selection 2017 ·Clinical Cancer Research ·Franziska Niehr, (unknown), (unknown), Robert Konschak, Denise Treue, Frederick Klauschen, Michael Bockmayr, Seval Türkmen, Korinna Jöhrens, Volker Budach, Ingeborg Tinhofer	41
10	TP53 mutation predicts sensitivity to adjuvant gemcitabine in pancreatic cancer: Results from the CONKO-001 study 2017 ·Annals of Oncology ·M. Sinn, Jan Budczies, Frédérik Damm, Philipp Lohneis, Rosa Schmuck, Denise Treue, Jana K. Striefler, Marcus Bahra, Uwe Pelzer, (unknown), Hendrik Bläker, Sven Bischoff, Helmut Oettle, Carsten Denkert, Hanno Riess, (unknown)	3
11	Ioncopy: a novel method for calling copy number alterations in amplicon sequencing data including significance assessment 2016 ·Oncotarget ·Jan Budczies, Nicole Pfarr, Albrecht Stenzinger, Denise Treue, Volker Endris, (unknown), Nikola Bangemann, Jens‐Uwe Blohmer, Manfred Dietel, Sibylle Loibl, Frederick Klauschen, Wilko Weichert, Carsten Denkert	20
12	Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancer 2015 ·BMC Clinical Pathology ·Ruža Arsenić, Denise Treue, Annika Lehmann, Michael Hummel, Manfred Dietel, Carsten Denkert, Jan Budczies	55
13	Modulation of Dendritic Cell Immunobiology via Inhibition of 3-Hydroxy-3-Methylglutaryl-CoA (HMG-CoA) Reductase 2014 ·PLoS ONE ·Tina Leuenberger, Caspar F. Pfueller, Felix Luessi, Ivo Bendix, Magdalena Paterka, Timour Prozorovski, Denise Treue, (unknown), Josephine Herz, Volker Siffrin, Carmen Infante‐Duarte, Frauke Zipp, Sonia Waiczies	12
14	Cancer beyond organ and tissue specificity: Next‐generation‐sequencing gene mutation data reveal complex genetic similarities across major cancers 2014 ·International Journal of Cancer ·Daniel Heim, Jan Budczies, Albrecht Stenzinger, Denise Treue, Peter Hufnagl, Carsten Denkert, Manfred Dietel, Frederick Klauschen	30
15	Semiconductor sequencing: how many flows do you need? 2014 ·Bioinformatics ·Jan Budczies, Michael Bockmayr, Denise Treue, Frederick Klauschen, Carsten Denkert	3
16	YB‐1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma 2010 ·International Journal of Cancer ·(unknown), Klaus Mantwill, (unknown), Emanuel Rognoni, Martina Anton, Atsuko Kasajima, Wilko Weichert, Denise Treue, Hermann Lage, Tibor Schuster, Jürgen Schlegel, Bernd Gänsbacher, Per Sonne Holm	27
17	Regulation of mRNA expression in drug-sensitive and drug-resistant gastric carcinoma cells is independent of YB-1 expression. 2010 ·PubMed ·Réka Kurucz, (unknown), Denise Treue, Hermann Lage	2
18	Effect of YB-1 on the regulation of micro RNA expression in drug-sensitive and drug-resistant gastric carcinoma cells. 2010 ·PubMed ·(unknown), Réka Kurucz, Denise Treue, Hermann Lage	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact